Dietary Tart Cherry and Fructooligosaccharides Promote Bone Health via the Gut Microbiota and Increased Bone Formation
Authors:
- Pelumi AdedigbaPAPelumi Adedigba
- John A. IceJIJohn A. Ice
- Sanmi E. AlakeSASanmi E. Alake
- Bethany HatterBHBethany Hatter
- Proapa IslamPIProapa Islam
- Ashlee N. Ford VersyptAshlee N. Ford Versypt
- Trina A. KnottsTKTrina A. Knotts
- Jerry RitcheyJRJerry Ritchey
- Edralin A. LucasELEdralin A. Lucas
- Brenda J. SmithBSBrenda J. Smith
Open Access
Abstract
Background/Objectives: Fructooligosaccharides (FOS) and dried tart cherry (TC) are examples of simple and complex (i.e., within a food matrix) prebiotics that have demonstrated promising osteoprotective activity. In this study, we examined how dietary supplementation with TC or FOS shapes the gut-bone axis to promote bone accrual in young adult mice, and the role of the gut microbiota in mediating these responses. Methods: Studies were performed using 10-wk-old female C57BL/6 mice (n = 10–12/group) fed a control diet or control diet supplemented with 10% TC or FOS for 10 wks alone or in combination with an antibiotic/anti-fungal cocktail to suppress the gut microbiota. The bone phenotype was characterized by dual-energy X-ray absorptiometry, micro-computed tomography and static and dynamic bone histomorphometry. The gut-microbiota was profiled and short chain fatty acids (SCFA) were assessed based on 16S rRNA profiling and gas chromatographic techniques, respectively. Results: FOS and TC enhanced bone structure, with FOS yielding more pronounced benefits across cortical and trabecular compartments. These skeletal improvements with FOS occurred in the absence of systemic changes in bone turnover markers but were accompanied by increases in local bone formation, osteoblast and osteocyte numbers, and bone mineralization in the femur. Both diets altered gut microbiota composition and increased fecal concentrations of the most abundant SCFAs (i.e., acetate, propionate and butyrate), but the response was greater with FOS. Suppression of the gut microbiota and fecal SCFAs with the antibiotic/anti-fungal cocktail inhibited the effects of FOS and TC on cortical bone, but induced unexpected improvements in the trabecular bone. Conclusions: These findings demonstrate differential effects of simple and complex prebiotics on the gut-bone axis in young adult female mice and support a role for SCFA in the cortical bone response, but not in the trabecular bone response with this model of gut microbiota suppression.Keywords
Funding Information
- National Center for Complementary and Integrative Health (NCCIH) (R15AT010725, R15AT010725-S1)
- Office of Dietary Supplements (ODS) of the National Institutes of Health (R15AT010725, R15AT010725-S1)
This publication has 76 references indexed in Scilit:
- An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent MechanismCalcified Tissue International, 2021
- The Gut Microbiome Is Altered in Postmenopausal Women With Osteoporosis and OsteopeniaJBMR Plus, 2020
- Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid-Induced OsteoporosisJournal of Bone and Mineral Research, 2019
- Hippuric acid and 3‐(3‐hydroxyphenyl) propionic acid inhibit murine osteoclastogenesis through RANKL‐RANK independent pathwayJournal of Cellular Physiology, 2019
- Sexually Dimorphic Influence of Neonatal Antibiotics on BoneJournal of Orthopaedic Research, 2019
- Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and PathophysiologyComprehensive Physiology, 2018
- Gut Microbiota, Immune System, and BoneCalcified Tissue International, 2017
- Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material PropertiesJournal of Bone and Mineral Research, 2017
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- The gut microbiota regulates bone mass in miceJournal of Bone and Mineral Research, 2012